YOSHIYAMA ANNIE (SVP, Finance) sold 3.1% of their position (4.17K shares) of ALLOGENE THERAPEUTICS, INC. on the open market
Open‑market sale worth $7.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/4/2026ACC: 0001737287-26-000005
Officer· SVP, Finance
Since Feb 2026
+226.35K
Net shares
Net buyer
$7.2K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
230.52K acquired · 4.17K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.17K
Price / share
$1.72
Trade value
$7.17K
% of position
3.1%
2/2/2026
134.49K→130.32K
Total
Net shares
−4.17K
Net value
-$7.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −4.17K | $1.72 | $7.17K | 3.1% | 134.49K | 130.32K |
| Total | −4.17K | -$7.17K | ||||||
Derivative Transactions2
Stock Option (Right to buy)
Direct
Converts to
Common Stock
179.69K shares
Shares
+179.69K
Strike price
1.87
Held after
179.69K
Exercisable
—
2/2/2026
Restricted Stock Unit
Direct
Converts to
Common Stock
50.83K shares
Shares
+50.83K
Strike price
Held after
50.83K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) Direct | Common Stock179.69K shares | 2/2/2026 | A · Award | +179.69K | 1.87 | — | 179.69K |
| Restricted Stock Unit Direct | Common Stock50.83K shares | 2/2/2026 | A · Award | +50.83K | — | 50.83K |